Enanta Pharmaceuticals
ENTA
#8345
Rank
โ‚ฌ0.27 B
Marketcap
9,58ย โ‚ฌ
Share price
-3.95%
Change (1 day)
2.06%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -โ‚ฌ43.27 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ65.25 Million. In 2025 the company made an earning of -โ‚ฌ57.2 Million, an increase over its 2024 earnings that were of -โ‚ฌ86.75 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ43.27 Million-24.35%
2025 -โ‚ฌ57.2 Million-34.07%
2024 -โ‚ฌ86.75 Million-23.87%
2023 -โ‚ฌ0.12 Billion4.39%
2022 -โ‚ฌ0.11 Billion-4.4%
2021 -โ‚ฌ0.12 Billion91.12%
2020 -โ‚ฌ59.75 Million-407.13%
2019 โ‚ฌ19.45 M-78.63%
2018 โ‚ฌ91.03 M117.97%
2017 โ‚ฌ41.76 M-574.65%
2016 -โ‚ฌ8.8 Million-110.83%
2015 โ‚ฌ81.27 M-4.5%
2014 โ‚ฌ85.09 M-638.53%
2013 -โ‚ฌ15.81 Million-137.98%
2012 โ‚ฌ41.6 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ23.43 B-52,291.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ13.88 B-31,011.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
โ‚ฌ7.77 B-17,423.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ4.51 B-10,144.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ6.87 B-15,414.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ10.65 B-23,818.01%๐Ÿ‡บ๐Ÿ‡ธ USA